Taking people in BelgiumPhase 1
Testing SAR447754 in healthy adults and adults with moderate-to-severe atopic dermatitis
Tests SAR447754 in healthy adults and in adults with atopic dermatitis.
Key facts
- Who runs it
- Sanofi-Aventis Recherche & Developpement
- Where
- Edegem, BelgiumSee the siteAlso in 6 other countries, 11 sites
- Trial code
- EU 2025-523826-41-00
- U1111-1328-7723
- Registry title
- A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 291 people, planned
- Started
- 25 Feb 2026
- Expected to end
- 9 May 2028
- Type of study
- Interventional
- Record updated
- 4 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy adults and adults with moderate-to-severe atopic dermatitis to test SAR447754 for the first time in people.
- Age
- 18 to 64 years
- Sex
- All sexes can join.
- Disease stage
- Moderate-to-severe atopic dermatitis (for the group with the skin condition); healthy adults can also join.
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Belgium
Also in 6 other countries, 11 sites
- SGS BelgiumEdegem, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Testing SAR447754 in healthy adults and adults with moderate-to-severe atopic dermatitisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Fit questions
- Built from 2025-523826-41-00, who can take part
- Record updated
- 4 September 2026